An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index; 10 of the 19 sources its claims cite were checked for support.
Abstract
Uncontrolled macrophage activation is now considered to be a critical event in the pathogenesis of chronic inflammatory diseases such as atherosclerosis, multiple sclerosis, and chronic venous leg ulcers. However, it is still unclear which environmental cues induce persistent activation of macrophages in vivo and how macrophage-derived effector molecules maintain chronic inflammation and affect resident fibroblasts essential for tissue homeostasis and repair. We used a complementary approach studying human subjects with chronic venous leg ulcers, a model disease for macrophage-driven chronic inflammation, while establishing a mouse model closely reflecting its pathogenesis. Here, we have shown that iron overloading of macrophages--as was found to occur in human chronic venous leg ulcers and the mouse model--induced a macrophage population in situ with an unrestrained proinflammatory M1 activation state. Via enhanced TNF-α and hydroxyl radical release, this macrophage population perpetuated inflammation and induced a p16(INK4a)-dependent senescence program in resident fibroblasts, eventually leading to impaired wound healing. This study provides insight into the role of what we believe to be a previously undescribed iron-induced macrophage population in vivo. Targeting this population may hold promise for the development of novel therapies for chronic inflammatory diseases such as chronic venous leg ulcers.
Overview
CoChat Summary
TL;DR
In human chronic venous leg ulcers and a mouse iron-overload model, iron loading induced an unrestrained proinflammatory M1 macrophage population coexpressing CD163 that persisted and impaired wound healing. These macrophages released TNFα and hydroxyl/peroxynitrite radicals, causing fibroblast p16INK4a-dependent senescence; iron chelation, macrophage depletion, or etanercept rescued healing in mice.
Key findings
- In CVU biopsies, CD68+ macrophages represented up to 80% of cells in wound margins and persistently expressed M1 markers iNOS and TNFα in all studied CVU biopsies (patients 1–5), whereas acute wounds showed only a transient increase at day 2 and reduction by day 5. Iron deposits were found in macrophages and extracellular space in all studied CVU samples (patients 1–5 and 12–16) but were absent in acute wounds.
- In iron-dextran-treated mice, iron accumulated in F4/80+ wound macrophages; these cells showed a persistent proinflammatory M1 profile (TNFα hi, IL-12 hi, CCR2 hi, Ly6C hi) with intermediate M2 markers at day 5. Iron-loaded mice had delayed wound healing at days 3, 5, 7, and 10, and desferrioxamine prevented iron loading and rescued the healing defect.
- TNFα was causal in the mouse model: etanercept injected at day 3 rescued impaired healing at days 5, 7, and 10; clodronate liposome macrophage depletion at day 4 improved healing and fully rescued delayed repair at day 10; recombinant TNFα delayed healing in control acute wounds.
- CVUs showed prevailing O2−· and OH·, increased 8OHdG and 3-nitrotyrosine, and γH2AX and p16INK4a expression in ulcer-adjacent fibroblasts but not CD18+ leukocytes; DFX or clodronate prevented γH2AX induction in iron-loaded mice.
Methods
- Human samples: 16 patients with nonhealing CVUs (CEAP C6) persisting >4 months; 5-mm biopsies from ulcer edge and healthy skin of the same leg; acute wounds in 5 healthy volunteers biopsied at days 1, 2, and 5. Analyses included immunohistochemistry, immunofluorescence, flow cytometry, dihydrorhodamine123 ROS detection, and Western blotting.
- Mouse model: 8- to 12-week-old C57BL/6 mice received iron-dextran (5 mg i.p. every 3 days for 21 days) or PBS-dextran; selected groups received DFX (6 mg), etanercept (25 µg/wound at days 3–6), recombinant TNFα (5,000 U/wound at days 2–4), or clodronate/PBS liposomes (12.5 mg/wound at day 4). Four 6-mm full-thickness excisional wounds were made, and wound areas were quantified.
- In vitro: human PBMC-derived macrophages were treated with IFNγ/LPS, dexamethasone/IL-4, or Fenton-mimicking conditions (10 µM Fe(III) chloride, 10 µM ascorbate, 50 µM H2O2). Statistics used mean ± SD, two-tailed Student’s t test or Mann-Whitney U test, with P < 0.05 considered significant.
Limitations
- Stated: the studies do not discern whether the unrestrained proinflammatory M1 population represents a continuum of functional states within the M1/M2 framework, nor whether the phenotype arises from differentiation of initial tissue macrophages or polarization of a distinct recruited population that replaces original macrophages.
- Stated: the effect of topically applied DFX on macrophages is not known, and it remains to be seen whether beneficial outcomes from topical corticosteroids reflect a switch to antiinflammatory macrophages; T cell involvement in the pro-oxidative ulcer environment also remains unresolved.
- Evident from the text: human data are largely observational/correlative with small sample sizes (16 CVU patients; some analyses used 5 acute wounds or 5 normal-skin samples), while causal rescue evidence comes from the mouse model; no human trial targeting this macrophage population is reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 0 Not valid · 6 Not checked · 66 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“there is evidence from 2 independent reports that intracellular iron activates NFκ B, the major transcription factor of genes including, among others, proinflammatory TNFα in a model of LPS-stimulated (59) or iron-loaded rat liver macrophages (60).”
What the sources say
- Supportedcites [59] Xiong, 2003, J Biol Chem. source
The Abstract reports that a rise in intracellular iron preceded NF-κB activation in LPS-stimulated hepatic macrophages, and that iron chelators blocked both responses. It also states that direct addition of ferrous iron to cultured hepatic macrophages activated NF-κB (page not specified in our copy). (LLM, conf=0.93)
- Partly supportedcites [60] sourceExperimental — accuracy not yet measured
The Results report that ferrous sulfate activates IκB kinase (IKK) in cultured rat hepatic macrophages and increases TNFα release. The paper links intracellular iron signaling to NFκB activation in its introductory discussion, but the reported iron-treatment experiment measures IKK activity, not NFκB activation itself. The claim therefore goes beyond what this paper directly shows for iron-loaded rat liver macrophages. (LLM, conf=0.84)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“we showed here that accelerated aging of ulcer resident fibroblasts was rather caused by the installment of a p16 INK4a -dependent senescence program in vivo.”
What the sources say
- Partly supportedcites [62] sourceExperimental — accuracy not yet measured
The Abstract reports that chronic wound fibroblasts had a shorter proliferative lifespan and earlier senescence than patient-matched normal fibroblasts. The Discussion (section labelled “IB Wall et al.”) suggests oxidative stress could explain this early senescence, but our copy does not establish a p16INK4a-dependent mechanism or show that it caused aging in vivo. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“topical application of infliximab, a chimeric IgG1 monoclonal antibody that binds with high affinity and specificity to the soluble and transmembrane TNFα , resulted in significant improvement of healing in 12 of 14 previously therapy-resistant CVUs (12).”
What the sources say
- Partly supportedcites [12] sourceExperimental — accuracy not yet measured
The Results report healing or substantial size reduction in many of the 14 therapy-resistant ulcers after topical infliximab, supporting the reported improvement. But Materials and methods identifies the 14 wounds as a mixed group, including traumatic leg ulcers and scrotal ulcers—not 14 chronic venous ulcers (CVUs). The study also describes a case series rather than a statistically significant treatment effect. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Our in vivo data corroborated and extended previous in vitro data that ulcer-derived fibroblast cultures undergo accelerated replicative senescence (62).”
What the sources say
- Supportedcites [62] source
The section “CWF have a decreased replicative life span compared with NF” reports that cultured fibroblasts from chronic venous leg ulcers became senescent after fewer population doublings than patient-matched normal fibroblasts. It also reports greater senescence-associated β-galactosidase activity in the ulcer-derived cultures at late passage. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The identification of iron accumulation in macrophages as the prime event in the complex pathogenesis of CVUs eventually driving persistent inflammation and tissue damage is also of major relevance for other chronic inflammatory disorders with enhanced iron storage in macrophages, like arteriosclerosis, multiple sclerosis, and other neurodegenerative diseases (79-82).”
What the sources say
- Partly supportedcites [79] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [80] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Could not verifycites [81] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [82] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
43 more claims
Create a free account to see all 78 claims and every source verdict.
- Probably not a substantial claim. 7
- It may state two separate claims as one. 26
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, in mouse and human skin wounds and in injured mouse kidney, Mp expression of CD206 increases during the later stages of repair [33,60,61,63].”
From Macrophage phenotypes during tissue repair (2013) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The M1-associated cytokines IL-1, TNF-␣, IL-6, and IL-12 are expressed by Mp during the first few hours to days after acute injury in numerous tissues, including skin [33,60,61], liver [62], kidney [63], and skeletal muscle [57,64].”
From Macrophage phenotypes during tissue repair (2013) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies by Sindrilaru et al. (2011) and Sindrilaru (2013) have identified a subset of iron-overloaded inflammatory M1-like macrophages, which are implicated in the pathogenesis of CVD.”
From The role of iron in the skin and cutaneous wound healing (2014) · cites this paper as Sindrilaru et al. (2011)
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, the reactive oxygen species (ROS) production by macrophages is also regulated by the balance of CB1 and CB2 activation, which is an important factor contributing to the persistent inflammation in chronic wounds and increasing the senescence of dermal fibroblasts [63, 110].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For example, iron overload drives macrophages into an unrestrained pro-inflammatory M1-activation state, and iron-overloaded macrophages have been detected in human chronic venous ulcers [63, 64].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [63]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Martin, R. (1986) · Medical Entomology and Zoology · Cited by 8,752
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Singer, A. J., & Clark, R. A. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411006 · Cited by 6,106
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Wound Healing--Aiming for Perfect Skin Regeneration
Martin, P. (1997) · Science · doi:10.1126/science.276.5309.75 · Cited by 4,804
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
Szabó, C., Ischiropoulos, H., & Radi, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2222 · Cited by 2,134
Martinez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,125
Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K., & Chazaud, B. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070075 · Cited by 2,002
Revision of the CEAP classification for chronic venous disorders: Consensus statement
Eklöf, B., Rutherford, R. B., Bergan, J. J., Carpentier, P. H., Gloviczki, P., Kistner, R. L., Meissner, M. H., Moneta, G. L., Myers, K., Padberg, F. T., et al. (2004) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.09.027 · Cited by 1,914
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum.
(1975) · PubMed Central · Cited by 1,437
Braun, J., Brandt, J., Listing, J., Zink, A., Alten, R., Golder, W., Gromnica-lhle, E., Kellner, H., Krause, A., Schneider, M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08215-6 · Cited by 1,261
Differential Roles of Macrophages in Diverse Phases of Skin Repair
Lucas, T., Waisman, A., Ranjan, R., Roes, J., Krieg, T., Müller, W., Roers, A., & Eming, S. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903356 · Cited by 1,205
Cellular Senescence in Aging Primates
Herbig, U., Ferreira, M., Condel, L., Carey, D., & Sedivy, J. M. (2006) · Science · doi:10.1126/science.1122446 · Cited by 1,101
Bergan, J. J., Schmid-Schönbein, G. W., Smith, P. D. C., Nicolaides, A. N., Boisseau, M. R., & Eklof, B. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055289 · Cited by 933
Why chronic wounds will not heal: a novel hypothesis
Bjarnsholt, T., Kirketerp‐Møller, K., Jensen, P. Ø., Madsen, K. G., Phipps, R., Krogfelt, K., Høiby, N., & Givskov, M. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00283.x · Cited by 886
Cytokine Signaling Modules in Inflammatory Responses
O'Shea, J. J., & Murray, P. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.002 · Cited by 818
The phagocytes: neutrophils and monocytes
Dale, D. C., Boxer, L., & Liles, W. C. (2008) · Blood · doi:10.1182/blood-2007-12-077917 · Cited by 740
Wound Fluid from Chronic Leg Ulcers Contains Elevated Levels of Metalloproteinases MMP-2 and MMP-9
Wysocki, A. B., Staiano-Coico, L., & Grinnell, F. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12359590 · Cited by 732
Goerdt, S., & Orfanos, C. E. (1999) · Immunity · doi:10.1016/s1074-7613(00)80014-x · Cited by 682
Robson, M. C. (1997) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70572-7 · Cited by 643
Ruffell, D., Mourkioti, F., Gambardella, A., Kirstetter, P., Lopez, R. G., Rosenthal, N., & Nerlov, C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908641106 · Cited by 626
Forsyth, J. M. (2022) · How to Be a Safe Consultant Vascular Surgeon from Day One · doi:10.1201/b23010-18 · Cited by 619
Anti-TNF-α therapies: the next generation
Palladino, M. A., Bahjat, F. R., Theodorakis, E. A., & Moldawer, L. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1175 · Cited by 576
p16 INK4A is a robust in vivo biomarker of cellular aging in human skin
Ressler, S., Bartkova, J., Niederegger, H., Bartek, J., Scharffetter‐Kochanek, K., Jansen‐Dürr, P., & Wlaschek, M. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00231.x · Cited by 557
Self-citationCauses of venous ulceration: a new hypothesis
Smith, P. D. C., Thomas, P., Scurr, J. H., & Dormandy, J. A. (1988) · BMJ · doi:10.1136/bmj.296.6638.1726 · Cited by 555
Regulation of iron acquisition and storage: consequences for iron-linked disorders
De Domenico, I., McVey Ward, D., & Kaplan, J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2295 · Cited by 464
Venous leg ulcer: Incidence and prevalence in the elderly
Margolisa, B., Bilkerb, C., Santannab, C., & Baumgartenc, D. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.121739 · Cited by 458
Cytokine-mediated regulation of iron transport in human monocytic cells
Ludwiczek, S., Aigner, E., Theurl, I., & Weiss, G. (2003) · Blood · doi:10.1182/blood-2002-08-2459 · Cited by 420
The inflammatory macrophage: a story of Jekyll and Hyde
DUFFIELD, J. S. (2003) · Clinical Science · doi:10.1042/cs1040027 · Cited by 414
TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens
Peyssonnaux, C., Zinkernagel, A. S., Datta, V., Lauth, X., Johnson, R. S., & Nizet, V. (2006) · Blood · doi:10.1182/blood-2005-06-2259 · Cited by 379
Biochemical analysis of acute and chronic wound environments
Tarnuzzer, R. W., & Schultz, G. S. (1996) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.1996.40307.x · Cited by 372
Expression and Proteolysis of Vascular Endothelial Growth Factor is Increased in Chronic Wounds
Lauer, G., Sollberg, S., Cole, M., Krieg, T., Eming, S. A., Flamme, I., Stürzebecher, J., & Mann, K. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00036.x · Cited by 349
Tang, H., Cao, W., Kasturi, S. P., Ravindran, R., Nakaya, H. I., Kundu, K., Murthy, N., Kepler, T. B., Malissen, B., & Pulendran, B. (2010) · Nature Immunology · doi:10.1038/ni.1883 · Cited by 313
Stadler, N., Lindner, R. A., & Davies, M. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000124892.90999.cb · Cited by 310
Yager, D. R., Chen, S. M., Ward, S. I., Olutoye, O. O., Diegelmann, R. F., & Kelman Cohen, I. (1997) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.1997.50108.x · Cited by 308
Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes
Liu, Y., Cousin, J. M., Hughes, J., Van Damme, J., Seckl, J. R., Haslett, C., Dransfield, I., Savill, J., & Rossi, A. G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3639 · Cited by 299
A stromal address code defined by fibroblasts
Parsonage, G., Filer, A. D., Haworth, O., Nash, G. B., Rainger, G. E., Salmon, M., & Buckley, C. D. (2005) · Trends in Immunology · doi:10.1016/j.it.2004.11.014 · Cited by 297
Wang, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27180 · Cited by 276
Autocrine formation of hepcidin induces iron retention in human monocytes
Theurl, I., Theurl, M., Seifert, M., Mair, S., Nairz, M., Rumpold, H., Zoller, H., Bellmann-Weiler, R., Niederegger, H., Talasz, H., et al. (2008) · Blood · doi:10.1182/blood-2007-05-090019 · Cited by 275
Reversing Lipopolysaccharide Toxicity by Ligating the Macrophage Fcγ Receptors
Gerber, J. S., & Mosser, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6861 · Cited by 263
Van Rooijen, N., Kors, N., Ende, M. V. D., & Dijkstra, C. D. (1990) · Cell and Tissue Research · doi:10.1007/bf00318625 · Cited by 262
Oxidative stress in chronic venous leg ulcers
Wlaschek, M., & Scharffetter‐Kochanek, K. (2005) · Wound Repair and Regeneration · doi:10.1111/j.1067-1927.2005.00065.x · Cited by 241
Self-citationInfection in chronic wounds: controversies in diagnosis and treatment.
Dow, G. T., Browne, A., & Sibbald, R. G. (1999) · PubMed · Cited by 240
Zamboni, P. (2006) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.99.11.589 · Cited by 239
Gelderman, K. A., Hultqvist, M., Pizzolla, A., Zhao, M., Nandakumar, K. S., Mattsson, R., & Holmdahl, R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31935 · Cited by 239
The inflammatory macrophage: a story of Jekyll and Hyde
Duffield, J. S. (2003) · Clinical Science · doi:10.1042/cs20020240 · Cited by 235
Fibroblast Dysfunction Is a Key Factor in the Non-Healing of Chronic Venous Leg Ulcers
Wall, I. B., Moseley, R., Baird, D. M., Kipling, D., Giles, P., Laffafian, I., Price, P. E., Thomas, D. W., & Stephens, P. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.114 · Cited by 226
Fibroblasts cultured from venous ulcers display cellular characteristics of senescence
Mendez, M. V., Stanley, A., Park, H.-Y., Shon, K., Phillips, T., & Menzoian, J. O. (1998) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(98)70064-3 · Cited by 202
Delayed Wound Healing in the Absence of Intercellular Adhesion Molecule-1 or L-Selectin Expression
Nagaoka, T., Kaburagi, Y., Hamaguchi, Y., Hasegawa, M., Takehara, K., Steeber, D. A., Tedder, T. F., & Sato, S. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64534-8 · Cited by 172
Chronic Venous Insufficiency and Varicose Veins
Raju, S., & Neglén, P. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0802444 · Cited by 171
Signaling Role of Intracellular Iron in NF-κB Activation
Xiong, S., She, H., Takeuchi, H., Han, B., Engelhardt, J. F., Barton, C. H., Zandi, E., Giulivi, C., & Tsukamoto, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210905200 · Cited by 161
Wound‐healing defect of CD18−/− mice due to a decrease in TGF‐β1 and myofibroblast differentiation
Peters, T., Sindrilaru, A., Hinz, B., Hinrichs, R., Menke, A., Al‐Azzeh, E. A. D., Holzwarth, K., Oreshkova, T., Wang, H., Kess, D., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600809 · Cited by 153
Self-citationGarinis, G. A., Uittenboogaard, L. M., Stachelscheid, H., Fousteri, M., van Ijcken, W., Breit, T. M., van Steeg, H., Mullenders, L. H. F., van der Horst, G. T. J., Brüning, J. C., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1866 · Cited by 138
Iron and 8-isoprostane levels in acute and chronic wounds
Yeoh-Ellerton, S., & Stacey, M. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12471.x · Cited by 125
Streit, M., Beleznay, Z., & Braathen, L. R. (2006) · International Wound Journal · doi:10.1111/j.1742-481x.2006.00233.x · Cited by 117
Revision of the CEAP classification for chronic venous disorders: a consensus statement
Eklöf, Rutherford, Bergan, Carpentier, Gloviczki, P., Kistner, Meissner, Moneta, Myers, Padberg, F. T., et al. (2005) · VASA · doi:10.1024/0301-1526.34.3.157 · Cited by 117
Causes and effects of the chronic inflammation in venous leg ulcers.
Ågren, M. S., Eaglstein, W. H., Ferguson, M. W. J., Harding, K. G., Moore, K., Saarialho‐Kere, U., & Schultz, G. (2000) · PubMed · Cited by 115
Wenk, J., Sabiwalsky, A., Dissemond, J., Meewes, C., Brenneisen, P., Wlaschek, M., Scharffetter-Kochanek, K., Foitzik, A., Achterberg, V., Reitz, A., et al. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01345.x · Cited by 115
Self-citationBorda, J. T., Alvarez, X., Mohan, M., Hasegawa, A., Bernardino, A., Jean, S., Aye, P., & Lackner, A. A. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070848 · Cited by 115
Primary Pulmonary Hypertension in HIV Patients: A Systematic Review
Pellicelli, A. M., Barbaro, G., Palmieri, F., Girardi, E., D'Ambrosio, C., Rianda, A., Barbarini, G., Frigiotti, D., Borgia, M. C., & Petrosillo, N. (2001) · Angiology · doi:10.1177/000331970105200105 · Cited by 114
Causes and effects of the chronic inflammation in venous leg ulcers.
Ågren, M., Eaglstein, W., Ferguson, M., Harding, K., Moore, K., Saarialho-Kere, U., & Schultz, G. S. (2000) · Acta Dermato-Venereologica · doi:10.1080/00015555210317 · Cited by 113
Wound Infection: A Failure of Wound Healing Caused by an Imbalance of Bacteria
Robson, M. C. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63661-9 · Cited by 112
Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration
Zamboni, P., Tognazzo, S., Izzo, M., Pancaldi, F., Scapoli, G. L., Liboni, A., & Gemmati, D. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.04.003 · Cited by 104
Leukocyte activation in patients with venous insufficiency
Takase, S., Schmid-Schönbein, G., & Bergan, J. J. (1999) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(99)70187-4 · Cited by 94
Ong, W.-Y., & Halliwell, B. B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.005 · Cited by 93
The iron hypothesis of atherosclerosis and its clinical impact
Yuan, X., & Li, W. (2003) · Annals of Medicine · doi:10.1080/07853890310016342 · Cited by 93
Clarke Moloney, M., Lyons, G. M., Breen, P., Burke, P. E., & Grace, P. A. (2006) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2005.08.003 · Cited by 83
Nahrendorf, M., Świrski, F. K., Aïkawa, E., Stangenberg, L., Würdinger, T., Figueiredo, J., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Cell Biology · doi:10.1083/jcb1795oia13 · Cited by 83
Protease inhibitors protect growth factor activity in chronic wounds
Wlaschek, M., Peus, D., Achterberg, V., Meyer-Ingold, W., & Scharffetter-Kochanek, K. (1997) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1997.tb03804.x · Cited by 81
Self-citationScharffetter, K., Heckmann, M., Hatamochi, A., Mauch, C., Stein, B., Riethmüller, G., Ziegler‐Heitbrock, H. W. L., & Krieg, T. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90098-0 · Cited by 78
Arnold, L., Henry, A., Poron, F., Baba‐Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K., & Chazaud, B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb1774oia7 · Cited by 77
The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis
Zamboni, P., Izzo, M., Tognazzo, S., Carandina, S., De Palma, M., Catozzi, L., Caggiati, A., Scapoli, G., & Gemmati, D. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.026 · Cited by 76
Sindrilaru, A., Peters, T., Schymeinsky, J., Oreshkova, T., Wang, H., Gompf, A., Mannella, F., Wlaschek, M., Sunderkötter, C., Rudolph, K. L., et al. (2009) · Blood · doi:10.1182/blood-2008-07-166702 · Cited by 73
Self-citationAckerman, Z. (1988) · Archives of Dermatology · doi:10.1001/archderm.1988.01670090032006 · Cited by 72
Salim, A. S. (1991) · World Journal of Surgery · doi:10.1007/bf01659062 · Cited by 70
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Pukstad, B. S., Ryan, L., Flo, T. H., Stenvik, J., Moseley, R., Harding, K., Thomas, D. W., & Espevik, T. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.05.003 · Cited by 65
Chen, L., Xiong, S., She, H., Lin, S. W., Wang, J., & Tsukamoto, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609273200 · Cited by 64
Rosner, K., Ross, C., Karlsmark, T., Petersen, A. A., Gottrup, F., & Vejlsgaard, G. L. (1995) · APMIS · doi:10.1111/j.1699-0463.1995.tb01109.x · Cited by 63
Update on Chronic-Venous-Insufficiency-Induced Inflammatory Processes
Smith, P. D. C. (2001) · Angiology · doi:10.1177/0003319701052001s05 · Cited by 58
Weyl, A., Vanscheidt, W., Weiss, J. M., Peschen, M., Schöpf, E., & Simon, J. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90432-6 · Cited by 57
Self-citationA Failure of Wound Healing Caused by an Imbalance of Bacteria
Robson, M. C. (1997) · Cited by 56
Use of topical corticosteroids on chronic leg ulcers
Hofman, D., Moore, K., Cooper, R., Eagle, M., & Cooper, S. (2007) · Journal of Wound Care · doi:10.12968/jowc.2007.16.5.27047 · Cited by 50
Maintenance infliximab for Crohn's disease
Hanauer, S. B. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11537-6 · Cited by 44
Sullivan, J. L., & Zacharski, L. R. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00830.x · Cited by 29
Deferoxamine decreases necrosis in dorsally based pig skin flaps.
Weinstein, G. S., Maves, M. D., & McCormack, M. L. (1989) · Otolaryngology–Head and Neck Surgery · doi:10.1177/019459988910100508 · Cited by 29
Deferoxamine Improves Left Ventricular Function in ß-Thalassemia
Grisaru, D., Goldfarb, A. W., Gotsman, M. S., Rachmilewitz, E. A., & Hasin, Y. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360240058011 · Cited by 19
Deferoxamine Improves Left Ventricular Function in ß-Thalassemia
Grisaru, D. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.146.12.2344 · Cited by 3
Research works printed but not linked: 2
- Dow, 1999, Ostomy Wound Manage., 45, 23
- Leibovich, 1975, Am J Pathol., 78, 71
Cited by
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
“In CVU, the iron overload in macrophages sustained their M1 activation, leading to ROS-mediated DNA damage, fibroblast cellular senescence, and defective tissue repair (41).”
InfluentialProtective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684
Wound repair and regeneration: Mechanisms, signaling, and translation
Eming, S. A., Martin, P., & Tomic-Canic, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009337 · Cited by 3,562
“It has been shown that increased proinflammatory cellular infiltrates composed largely of neutrophils and macrophages contribute to delayed healing in chronic ulcers (27, 28).”
Macrophage plasticity and polarization in tissue repair and remodelling
Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., & Locati, M. (2013) · The Journal of Pathology · doi:10.1002/path.4133 · Cited by 2,384
Metadata
- Authors
- Sindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S., Qi, Y., Schlecht, A., Weiss, J. M., Wlaschek, M., Sunderkötter, C., & Scharffetter-Kochanek, K.
- Affiliations
- Universität Ulm (DE)
- University of Münster (DE)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-03-01
- Volume
- 121
- Issue
- 3
- Pages
- 985-997
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3049372
- OpenAlex
- W2019583561
- Cited by
- 1,100
- References
- 92
- Citations by year
- 2026: 50 · 2025: 61 · 2024: 95 · 2023: 80 · 2022: 77 · 2021: 87 · 2020: 76 · 2019: 87 · 2018: 85 · 2017: 90 · 2016: 75 · 2015: 60 · 2014: 64 · 2013: 49 · 2012: 39
- FWCI
- 56.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Baden-Württemberg Stiftung
- European Commission (223236)
- Deutsche Forschungsgemeinschaft (SU 195/3-1, KFO 142, SFB 497)
- Universität Ulm
- Topics
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Surgery › Diagnosis and Treatment of Venous Diseases
- Keywords
- M1 macrophages, chronic venous leg ulcers, wound healing, chronic inflammation, fibroblast senescence, p16INK4a, TNF-α, hydroxyl radicals, macrophage activation, tissue repair
- MeSH terms
- Animals, Fibroblasts, Humans, Inflammation, Iron, Macrophages, Models, Biological, Phenotype, Tumor Necrosis Factor-alpha, Wound Healing, Cellular Senescence, Reactive Oxygen Species, Hydroxyl Radical, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.





